PL-17 risk and management of thrombosis in multiple myeloma

Frank W.G. Leebeek*, Marieke J.H.A. Kruip, Pieter Sonneveld

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)

Abstract

Patients diagnosed with multiple myeloma have an increased risk of venous thrombosis. This may be due to various risk factors, including disease specific factors, changes in coagulation and fibrinolysis factors and circulating prothrombotic microparticles. More recent studies have indicated that also arterial thrombosis, including acute myocardial infarction and stroke do occur more frequently in these patients. Studies on etiological factors contributing to the development of thrombosis will be reviewed in this article. In addition we will focus on the prevention and management of arterial and venous thrombosis in patients with multiple myeloma.

Original languageEnglish
Pages (from-to)S88-S92
JournalThrombosis Research
Volume129
Issue numberSUPPL. 1
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Dive into the research topics of 'PL-17 risk and management of thrombosis in multiple myeloma'. Together they form a unique fingerprint.

Cite this